title: Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs).
abstract: The National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) is an independent scientific organization that is based in the United Kingdom, which was set up by the government to lead the discovery and application of new technologies and approaches that minimize the use of animals in research and improve animal welfare. The NC3Rs uses a range of strategies to improve and advance science through application of the 3Rs. These include funding basic research, open innovation (CRACK IT), and programs run by inhouse scientists. We present several case studies from the NC3Rs portfolio, featuring asthma research, the use of nonhuman primates in monoclonal antibody development, and CRACK IT. Finally, we anticipate the future, as we use our experience to move into new research fields and expand toward international collaboration. Here we highlight how equipping scientists with relevant and emerging 3Rs tools can help overcome the challenges and limitations of the use of animals in research to the benefit of the whole bioscience community.
authors.affiliation: The National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK. natalie.burden@nc3rs.org.uk.
authors.forename: Natalie
authors.initials: N
authors.lastname: Burden
authors.affiliation: The National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Chapman
authors.affiliation: The National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK.
authors.forename: Fiona
authors.initials: F
authors.lastname: Sewell
authors.affiliation: The National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK.
authors.forename: Vicky
authors.initials: V
authors.lastname: Robinson
mesh_terms: D032761:Animal Experimentation; D000827:Animal Welfare; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D003299:Cooperative Behavior; D004195:Disease Models, Animal; D004345:Drug Industry; D011323:Primates; D006113:United Kingdom
references.citation: Organogenesis. 2009 Apr;5(2):67-72
references.pmid: 19794902
references.citation: Hum Exp Toxicol. 2011 Mar;30(3):217-38
references.pmid: 20488841
references.citation: Lab Anim. 2009 Apr;43 Suppl 1:1-47
references.pmid: 19286892
references.citation: Regen Med. 2009 Jul;4(4):579-92
references.pmid: 19580406
references.citation: Toxicol Lett. 2010 Nov 30;199(2):111-4
references.pmid: 20832457
references.citation: Hum Exp Toxicol. 2011 Mar;30(3):239-49
references.pmid: 20488847
references.citation: Chemosphere. 2013 Jan;90(3):1300-4
references.pmid: 23040052
references.citation: Lab Anim. 2005 Jan;39(1):1-39
references.pmid: 15703122
references.citation: PLoS Biol. 2010;8(6):e1000412
references.pmid: 20613859
references.citation: Br J Pharmacol. 2009 Jul;157(6):865-80
references.pmid: 19371333
references.citation: Regul Toxicol Pharmacol. 2013 Jun;66(1):88-103
references.pmid: 23524271
references.citation: Crit Rev Toxicol. 2010 Jan;40(1):50-83
references.pmid: 20144136
references.citation: Chemosphere. 2014 Feb;96:195-200
references.pmid: 24183622
references.citation: Osteoarthritis Cartilage. 2012 Apr;20(4):253-5
references.pmid: 22321718
references.citation: Lab Chip. 2010 Jun 21;10(12):1611-7
references.pmid: 20379587
references.citation: Br J Pharmacol. 2009 Jul;157(6):863-4
references.pmid: 19624682
references.citation: Regul Toxicol Pharmacol. 2013 Oct;67(1):27-38
references.pmid: 23602904
references.citation: Nat Biotechnol. 2014 Jan;32(1):40-51
references.pmid: 24406927
references.citation: Regul Toxicol Pharmacol. 2008 Apr;50(3):345-52
references.pmid: 18295384
references.citation: Nat Rev Drug Discov. 2004 Aug;3(8):711-5
references.pmid: 15286737
references.citation: Mutagenesis. 2012 Jan;27(1):93-101
references.pmid: 21852270
references.citation: J Pharm Sci. 2011 Oct;100(10):4518-35
references.pmid: 21710508
references.citation: Eur Heart J. 2011 Oct;32(19):2340
references.pmid: 22066146
references.citation: Br J Pharmacol. 2012 Mar;165(6):1848-67
references.pmid: 21913900
references.citation: Regul Toxicol Pharmacol. 2009 Dec;55(3):291-9
references.pmid: 19665509
references.citation: Drug Discov Today. 2014 May;19(5):528-32
references.pmid: 24448068
references.citation: Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1039-48
references.pmid: 19611405
references.citation: Drug Discov Today. 2010 Mar;15(5-6):235-42
references.pmid: 20096369
references.citation: J Neurosci Methods. 2010 Nov 30;193(2):167-88
references.pmid: 20868708
references.citation: J Appl Anim Welf Sci. 2003;6(3):157-61
references.pmid: 14612264
references.citation: Int J Toxicol. 2011 Oct;30(5):583-90
references.pmid: 22013138
references.citation: MAbs. 2009 Sep-Oct;1(5):505-16
references.pmid: 20065651
references.citation: Dis Model Mech. 2011 May;4(3):281-2
references.pmid: 21555328
references.citation: Regul Toxicol Pharmacol. 2012 Mar;62(2):241-7
references.pmid: 22198561
references.citation: Regul Toxicol Pharmacol. 2012 Mar;62(2):347-54
references.pmid: 22100994
references.citation: Neurosci Biobehav Rev. 2011 Jan;35(3):912-38
references.pmid: 21036191
references.citation: Nat Rev Drug Discov. 2007 Feb;6(2):120-6
references.pmid: 17268483
references.citation: Drug Discov Today. 2011 Aug;16(15-16):659-70
references.pmid: 21723955
references.citation: Nat Rev Drug Discov. 2010 Mar;9(3):203-14
references.pmid: 20168317
references.citation: Regul Toxicol Pharmacol. 2014 Oct;70(1):413-29
references.pmid: 25078890